Stockreport

Allogene: ALLO-715 Phase 1 Results And ALLO-213 Preclinical Data Is Promising [Seeking Alpha]

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report
PDF luismmolinaAllogene Therapeutics (NASDAQ:ALLOCAR T (AlloCAR T)of cutting-edge technology that could revolutionize cancer therapy.One of the main advantages of Allogene's [Read more]